Zobrazeno 1 - 10
of 92
pro vyhledávání: '"A1chieve study"'
Autor:
Dae Wook Lee, Sun Ok Song, Kyu Jeung Ahn, Young Duk Song, Byung Wan Lee, You-Cheol Hwang, Bong Soo Cha
Publikováno v:
Diabetes Therapy
Introduction A1chieve® (ClinicalTrials.gov identifier NCT00869908) was a 24-week observational study evaluating certain insulin analogs and not insulin analogs in general in 66,726 people with type 2 diabetes (T2D) in routine clinical care in 28 non
Autor:
Lenita Zajdenverg, Jihad Haddad, Andreas Liebl, Issam Hajjaji, Hoosen Randeree, Mohammad E. Khamseh, Jian-Wen Chen
Publikováno v:
Diabetes Therapy
Introduction This sub-analysis evaluated clinical safety and effectiveness of bolus insulin aspart [with/without oral glucose-lowering drugs (OGLDs)] as the only insulin therapy. Methods A1chieve was an international, multicenter, prospective, open-l
Publikováno v:
Indian Journal of Endocrinology and Metabolism
Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 8, Pp 538-541 (2013)
Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 8, Pp 538-541 (2013)
Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical ca
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 8, Pp 449-452 (2013)
Indian Journal of Endocrinology and Metabolism
Indian Journal of Endocrinology and Metabolism
Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical ca
Publikováno v:
Indian Journal of Endocrinology and Metabolism
Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 8, Pp 542-546 (2013)
Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 8, Pp 542-546 (2013)
Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical ca
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 8, Pp 445-448 (2013)
Indian Journal of Endocrinology and Metabolism
Indian Journal of Endocrinology and Metabolism
Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical ca
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 8, Pp 526-529 (2013)
Indian Journal of Endocrinology and Metabolism
Indian Journal of Endocrinology and Metabolism
Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical ca
Autor:
Henda Jamoussi, Samira Blouza
Publikováno v:
Indian Journal of Endocrinology and Metabolism
Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 8, Pp 426-430 (2013)
Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 8, Pp 426-430 (2013)
Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical ca
Autor:
Mustafa Al Abousi
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 8, Pp 482-485 (2013)
Indian Journal of Endocrinology and Metabolism
Indian Journal of Endocrinology and Metabolism
Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical ca
Autor:
Jothydev Kesavadev
Publikováno v:
Indian Journal of Endocrinology and Metabolism
Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 8, Pp 565-568 (2013)
Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 8, Pp 565-568 (2013)
Background: The A1chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM ( n = 66,726) in routine clinical car